Pharmaceuticals

RNA Targeting Small Molecules Therapeutics Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the rna targeting small molecules therapeutics market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The RNA Targeting Small Molecules Therapeutics Market And What Value Is Projected For 2029?

The market size for influenza treatment has demonstrated consistent growth over recent years. It is forecast to expand from $6.6 billion in 2024 to $6.83 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.4%. The historical expansion of this market can be attributed to several factors, including an increase in the annual number of influenza cases, heightened government funding for influenza research and preparedness programs, public awareness campaigns encouraging vaccination, the establishment of global influenza surveillance systems, and the growth in healthcare facilities.

The influenza treatment market is projected for consistent expansion over the coming years, with its size anticipated to reach $7.93 billion in 2029, reflecting a compound annual growth rate (CAGR) of 3.8%. This projected increase throughout the forecast period is attributable to the introduction of new antiviral drugs and treatment modalities, expanding vaccination programs, ongoing development and enhancement of healthcare infrastructure, a growing elderly population, and the development of novel treatments. Major trends expected in the forecast period include advancements in developing universal vaccines, innovations in vaccine delivery systems, the integration of AI and big data, progress in personalized medicine, and increased collaborations among pharmaceutical companies.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15832&type=smp

What Factors Are Boosting The RNA Targeting Small Molecules Therapeutics Market?

The growing occurrence of contagious respiratory illnesses is projected to drive the influenza treatment market forward. Contagious respiratory illness refers to infectious conditions, including influenza, measles, or respiratory syncytial virus (RSV) infections, which spread through contact with an infected person, their bodily fluids, or contaminated surfaces and objects. Factors contributing to the rise of contagious respiratory illness encompass higher population densities, inadequate healthcare infrastructure, the misuse of antibiotics, and streamlined international travel. Influenza treatment comprises antiviral drugs and vaccinations utilized to address various contagious respiratory illnesses such as flu, COVID-19, and other respiratory viruses. For example, in September 2023, data from the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, indicated that hospitalizations related to RSV (Respiratory Syncytial Virus) climbed from 2 hospitalizations per 100,000 people during the week ending August 5, 2023, to 7 hospitalizations per 100,000 individuals by the week concluding on August 19, 2023. Consequently, the heightened prevalence of contagious respiratory illnesses is stimulating the growth of the influenza treatment market.

What Are The Core Segmentation Criteria In The RNA Targeting Small Molecules Therapeutics Market?

The influenza treatment market covered in this report is segmented –

1) By Product Type: Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil, Other Products

2) By Route Of Administration: Oral, Other Routes Of Administration

3) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Other Distribution Channels

Subsegments:

1) By Peramivir: Intravenous Peramivir, Peramivir Injection

2) By Zanamivir: Inhaled Zanamivir, Zanamivir Diskhaler

3) By Oseltamivir Phosphate: Oseltamivir Capsules, Oseltamivir Oral Suspension

4) By Baloxavir Marboxil: Baloxavir Tablets, Baloxavir Granules For Oral Suspension

5) Other Products: Rimantadine, Amantadine

Which Emerging Trends Are Reshaping The RNA Targeting Small Molecules Therapeutics Market Landscape?

Leading firms in the influenza treatment market are concentrating on broadening their product offerings through the introduction of novel solutions, like single-dose oral medicines for influenza treatment, with the aim of boosting patient adherence, refining treatment efficacy, and securing a greater portion of the market. Such a medicine is defined as a pharmaceutical product intended to address influenza (flu) via a sole oral administration, thereby streamlining the treatment process. An example is Genentech Inc., a US-based biotechnology company, which revealed in August 2022 that its product Xofluza (Baloxavir Marboxil) had received approval from the U.S. Food and Drug Administration (FDA). Xofluza represents the initial and sole single-dose oral medication providing an accessible and effective method for handling acute uncomplicated influenza in children between the ages of five to less than 12 years, provided they have shown symptoms for no more than 48 hours, as well as for other respiratory viruses.

Which Players Are Shaping The Competitive Landscape Of The RNA Targeting Small Molecules TherapeuticsXX Market?

Major companies operating in the influenza treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Fujifilm Holdings Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd., Janssen Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited., Chugai Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Limited, NATCO Pharma Limited, BioCryst Pharmaceuticals Inc., NanoViricides Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

What Regional Trends Are Shaping Growth In The RNA Targeting Small Molecules Therapeutics Market?

North America was the largest region in the influenza treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15832&type=smp

Browse Through More Reports Similar to the Global RNA Targeting Small Molecules Therapeutics Market 2025, By The Business Research Company

Gastrointestinal Bleeding Treatment Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Industrial Water Treatment Chemicals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/industrial-water-treatment-chemicals-global-market-report

Point Of Use Water Treatment Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-use-water-treatment-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795